Skip to main content
HeartCited

Folate (Vitamin B9) pour Coronary Artery Disease (CAD)

C

CSPPT showed stroke benefit but not MI benefit. HOPE-2 was negative for cardiovascular events despite homocysteine reduction. Research suggests benefit may be limited to populations without folic acid fortification.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dfolate\u0026condition\u003Dcoronary\u002Dartery\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            C

        

        

            
En conclusion

            
            
CSPPT showed stroke benefit but not MI benefit. HOPE-2 was negative for cardiovascular events despite homocysteine reduction. Research suggests benefit may be limited to populations without folic acid fortification.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
10

        
Études

    

    

        
40000

        
Participants

    

    

        
            
            ↔
            
        
        
Mixed

    

    

        C

        
Note

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Posologies couramment utilisées

                

                    
                    

                        
general:

                        
400 mcg DFE/day

                    

                    
                    

                        
homocysteinereduction:

                        
400-800 mcg/day folic acid (with B12 and B6)

                    

                    
                

                
                

                    Limite supérieure : 1,000 mcg/day folic acid from supplements
                

                
            

            

            

            
            

                Moment optimal de prise : With or without food; consistent daily timing preferred
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Effets indésirables signalés

                    
    
                        
                        
  • 
                            ⚠
                            Generally very well-tolerated
                        
    • 
                        
                        
  • 
                            ⚠
                            May mask vitamin B12 deficiency at high doses
                        
    • 
                        
                        
  • 
                            ⚠
                            Rare: mild gastrointestinal discomfort
                        
    • 
                        
                    

                

                

                
                

                    
Interactions connues

                    
    
                        
                        
  • 
                            ●
                            Methotrexate (folate may reduce efficacy)
                        
    • 
                        
                        
  • 
                            ●
                            Antiepileptic drugs (phenytoin, carbamazepine — mutual interference)
                        
    • 
                        
                        
  • 
                            ●
                            Vitamin B12 (co-supplementation recommended for homocysteine reduction)
                        
    • 
                        
                    

                

                

                
                

                    

                        Apport maximal tolérable : 1,000 mcg/day folic acid from supplements
                    

                

                
            

            

                Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Folate (Vitamin B9) help with Coronary Artery Disease (CAD)?
            
        
        

            Based on 10 studies with 40,000 participants, there is limited but promising evidence that Folate (Vitamin B9) may support Coronary Artery Disease (CAD) management. Our evidence grade is C (Some Evidence).
        

    

    
    

        
            How much Folate (Vitamin B9) should I take for Coronary Artery Disease (CAD)?
            
        
        

            Studies have used various dosages. A commonly studied range is 400 mcg DFE/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Folate (Vitamin B9)?
            
        
        

            Reported side effects may include Generally very well-tolerated, May mask vitamin B12 deficiency at high doses, Rare: mild gastrointestinal discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Folate (Vitamin B9) and Coronary Artery Disease (CAD)?
            
        
        

            We rate the evidence as Grade C (Some Evidence). This rating is based on 10 peer-reviewed studies with 40,000 total participants. The overall direction of effect is mixed.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                

                    
Autres ingrédients pour Coronary Artery Disease (CAD)

                    

                        
                        
                            Omega-3 Fatty Acids (EPA/DHA)
                            B

                        
                        
                        
                            Magnesium
                            C

                        
                        
                        
                            Selenium
                            C

                        
                        
                    

                

                

                
                

                    
Folate (Vitamin B9) pour d'autres pathologies

                    

                        
                        
                            Elevated Homocysteine (Hyperhomocysteinemia)
                            B

                        
                        
                    

                

                
            

        

        

    


    
    












    

        Avertissement FDA:
        Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.